Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis
Abstract Introduction The question remains to be elucidated: “Is treatment with antidepressants at doses approved in Japan effective for Japanese patients with MDD?” It is crucial to confirm this in order to provide appropriate treatments for Japanese patients with major depressive disorder (MDD). T...
Main Authors: | Taro Kishi, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Hikaru Hori, Masaki Kato, Nakao Iwata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12376 |
Similar Items
-
Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta‐analysis
by: Taro Kishi, et al.
Published: (2024-03-01) -
Repetitive transcranial magnetic stimulation for preventing relapse in antidepressant treatment-resistant depression: A systematic review and meta-analysis of randomized controlled trials
by: Yuki Matsuda, et al.
Published: (2023-03-01) -
Comparative effectiveness-safety of conventional versus newer antiepileptics in epileptic patients in a tertiary care hospital, India
by: Meenu Thomas, et al.
Published: (2023-12-01) -
Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis
by: Taro Kishi, et al.
Published: (2024-03-01) -
Antidepressants /
by: Dudley, William, 1964-
Published: (2005)